Comparison of prevalence, clinical evolution and vaccination rate against COVID 19 in a population of patients diagnosed with Dual Bipolar disorder and Non-dual bipolar disorder
Introduction Since the beginning of the pandemic, 4,745,519 cases, 396,878 hospitalizations and 82,884 deaths with COVID-19 have been reported in Spain. As of August 24, 2021, 76.4% of Andalusians over 12 years of age have the complete vaccination regimen. Objectives Main: to calculate the prevalenc...
Saved in:
Published in | European psychiatry Vol. 65; no. S1; pp. S408 - S409 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Paris
Cambridge University Press
01.06.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Introduction
Since the beginning of the pandemic, 4,745,519 cases, 396,878 hospitalizations and 82,884 deaths with COVID-19 have been reported in Spain. As of August 24, 2021, 76.4% of Andalusians over 12 years of age have the complete vaccination regimen.
Objectives
Main: to calculate the prevalence of COVID 19 infection, clinical evolution, and vaccination rate in a population of patients diagnosed with dual bipolar disorder. Secondary: compare these data with those obtained inpatients diagnosed with non-dual bipolar disorder.
Methods
Retrospective descriptive study. The study population is made up of patients diagnosed with dual bipolar disorder and non-dual bipolar disorder (according to DSM 5 criteria). Infection, admission, death, and vaccination data were obtained from the patient’s medical history.
Results
Of the 7 patients diagnosed with dual bipolar disorder, the prevalence of COVID 19 infection, since the beginning of the pandemic is 0% and of the 21 patients diagnosed with non-dual bipolar disorder the prevalence is 9.51% (2/21). Of the patients with COVID 19 infection, none required hospital admission and no deaths occurred. The vaccination rate in the group of patients with dual bipolar disorder is 85,71% (6/7) and in the group of non-dual bipolar disorder is 61.91% (13/21), no finding statistically significant differences between both groups.
Conclusions
In our study the prevalence of COVID 19 infection inpatients diagnosed with dual bipolar disorder is 0% and the vaccination rate is 85.71%. While in patients with non-dual bipolar disorder the prevalence is 9.51%, there were no admissions, no deaths and the vaccination rate is 61.91%.
Disclosure
No significant relationships. |
---|---|
AbstractList | Introduction Since the beginning of the pandemic, 4,745,519 cases, 396,878 hospitalizations and 82,884 deaths with COVID-19 have been reported in Spain. As of August 24, 2021, 76.4% of Andalusians over 12 years of age have the complete vaccination regimen. Objectives Main: to calculate the prevalence of COVID 19 infection, clinical evolution, and vaccination rate in a population of patients diagnosed with dual bipolar disorder. Secondary: compare these data with those obtained inpatients diagnosed with non-dual bipolar disorder. Methods Retrospective descriptive study. The study population is made up of patients diagnosed with dual bipolar disorder and non-dual bipolar disorder (according to DSM 5 criteria). Infection, admission, death, and vaccination data were obtained from the patient’s medical history. Results Of the 7 patients diagnosed with dual bipolar disorder, the prevalence of COVID 19 infection, since the beginning of the pandemic is 0% and of the 21 patients diagnosed with non-dual bipolar disorder the prevalence is 9.51% (2/21). Of the patients with COVID 19 infection, none required hospital admission and no deaths occurred. The vaccination rate in the group of patients with dual bipolar disorder is 85,71% (6/7) and in the group of non-dual bipolar disorder is 61.91% (13/21), no finding statistically significant differences between both groups. Conclusions In our study the prevalence of COVID 19 infection inpatients diagnosed with dual bipolar disorder is 0% and the vaccination rate is 85.71%. While in patients with non-dual bipolar disorder the prevalence is 9.51%, there were no admissions, no deaths and the vaccination rate is 61.91%. Disclosure No significant relationships. IntroductionSince the beginning of the pandemic, 4,745,519 cases, 396,878 hospitalizations and 82,884 deaths with COVID-19 have been reported in Spain. As of August 24, 2021, 76.4% of Andalusians over 12 years of age have the complete vaccination regimen.ObjectivesMain: to calculate the prevalence of COVID 19 infection, clinical evolution, and vaccination rate in a population of patients diagnosed with dual bipolar disorder. Secondary: compare these data with those obtained inpatients diagnosed with non-dual bipolar disorder.MethodsRetrospective descriptive study. The study population is made up of patients diagnosed with dual bipolar disorder and non-dual bipolar disorder (according to DSM 5 criteria). Infection, admission, death, and vaccination data were obtained from the patient’s medical history.ResultsOf the 7 patients diagnosed with dual bipolar disorder, the prevalence of COVID 19 infection, since the beginning of the pandemic is 0% and of the 21 patients diagnosed with non-dual bipolar disorder the prevalence is 9.51% (2/21). Of the patients with COVID 19 infection, none required hospital admission and no deaths occurred. The vaccination rate in the group of patients with dual bipolar disorder is 85,71% (6/7) and in the group of non-dual bipolar disorder is 61.91% (13/21), no finding statistically significant differences between both groups.ConclusionsIn our study the prevalence of COVID 19 infection inpatients diagnosed with dual bipolar disorder is 0% and the vaccination rate is 85.71%. While in patients with non-dual bipolar disorder the prevalence is 9.51%, there were no admissions, no deaths and the vaccination rate is 61.91%.DisclosureNo significant relationships. Introduction Since the beginning of the pandemic, 4,745,519 cases, 396,878 hospitalizations and 82,884 deaths with COVID-19 have been reported in Spain. As of August 24, 2021, 76.4% of Andalusians over 12 years of age have the complete vaccination regimen. Objectives Main: to calculate the prevalence of COVID 19 infection, clinical evolution, and vaccination rate in a population of patients diagnosed with dual bipolar disorder. Secondary: compare these data with those obtained inpatients diagnosed with non-dual bipolar disorder. Methods Retrospective descriptive study. The study population is made up of patients diagnosed with dual bipolar disorder and non-dual bipolar disorder (according to DSM 5 criteria). Infection, admission, death, and vaccination data were obtained from the patient’s medical history. Results Of the 7 patients diagnosed with dual bipolar disorder, the prevalence of COVID 19 infection, since the beginning of the pandemic is 0% and of the 21 patients diagnosed with non-dual bipolar disorder the prevalence is 9.51% (2/21). Of the patients with COVID 19 infection, none required hospital admission and no deaths occurred. The vaccination rate in the group of patients with dual bipolar disorder is 85,71% (6/7) and in the group of non-dual bipolar disorder is 61.91% (13/21), no finding statistically significant differences between both groups. Conclusions In our study the prevalence of COVID 19 infection inpatients diagnosed with dual bipolar disorder is 0% and the vaccination rate is 85.71%. While in patients with non-dual bipolar disorder the prevalence is 9.51%, there were no admissions, no deaths and the vaccination rate is 61.91%. Disclosure No significant relationships. |
Author | Losilla Rodríguez, B. Ortiz Jiménez, M. Palermo Zeballos, F. |
AuthorAffiliation | Hospital Universitario Virgen Macarena , Psychiatry, Sevilla , Spain |
AuthorAffiliation_xml | – name: Hospital Universitario Virgen Macarena , Psychiatry, Sevilla , Spain |
Author_xml | – sequence: 1 givenname: B. surname: Losilla Rodríguez fullname: Losilla Rodríguez, B. – sequence: 2 givenname: F. surname: Palermo Zeballos fullname: Palermo Zeballos, F. – sequence: 3 givenname: M. surname: Ortiz Jiménez fullname: Ortiz Jiménez, M. |
BookMark | eNpdktGO1CAUholZE2dXX8ArEm_tLJRS6I2Jzuo6yca9UW_JKdBZmg5UaMfsY_mG0unGZL0Czv_nOxz4L9GFD94i9JaSLaVNed1v7RzH9LgtSVluKWHiBdpQIWTBuOQXaEOasioaxuQrdJlSTwgVhNQb9GcXjiNEl4LHocNjtCcYrNf2PdaD807DgO0pDPPksgO8wSfQ2nk4nyNMFsMBnE8T3t3_3N9g2mCXjXgM4zysroWbd9ZPCRsHBx-SNfi3mx7wzZz5n9wYBohZSyEaG89tvgVfmEVt_1Nfo5cdDMm-eVqv0I8vn7_vvhZ397f73ce7QpesFoVkvKnqVpqKdwyEIKJtdZ5ZdB2rjOatqGTFOguSUM0Yt5oIwWoqcq0x-aWu0H7lmgC9GqM7QnxUAZw6F0I8KIiT04NVloOmrTGCd7xqSpBNRapaWzAdaQnUmfVhZY1ze7RG56eIMDyDPle8e1CHcFINrwWVy2XePQFi-DXbNKk-zNHn-VUpiBT5N8smu8rVpWNIKdruXwdK1JIT1as1J2rJiVpywv4ChFy42A |
ContentType | Journal Article |
Copyright | The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2022 2022 The Author(s) |
Copyright_xml | – notice: The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2022 2022 The Author(s) |
DBID | AAYXX CITATION 3V. 7XB 88G 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FYUFA GHDGH GNUQQ M2M PIMPY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 5PM DOA |
DOI | 10.1192/j.eurpsy.2022.1037 |
DatabaseName | CrossRef ProQuest Central (Corporate) ProQuest Central (purchase pre-March 2016) Psychology Database (Alumni) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College Coronavirus Research Database ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Psychology Database Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest One Psychology ProQuest Central Student ProQuest Central Basic ProQuest Central Essentials ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central Health Research Premium Collection ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest Central Korea ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | Publicly Available Content Database CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: COVID name: Coronavirus Research Database url: https://proxy.k.utb.cz/login?url=https://search.proquest.com/coronavirus sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1778-3585 |
EndPage | S409 |
ExternalDocumentID | oai_doaj_org_article_e5ac1bdd75f5492a894046ceadf0b0a6 10_1192_j_eurpsy_2022_1037 |
GroupedDBID | --- --K --M .1- .FO .~1 09C 09E 0R~ 0SF 1B1 1P~ 1~. 1~5 29G 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8FI 8FJ 8P~ AABNK AACTN AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AANRG AAOAW AAQXK AASVR AAXUO AAYXX ABBQC ABBZL ABFNM ABIVO ABJNI ABMZM ABUWG ABVZP ABXAU ABXDB ACDAQ ACGFS ACHQT ACIUM ACQPF ACZWT ADAZD ADBBV ADDNB ADEZE ADKIL ADMUD ADOVH ADVJH ADVLN AEBAK AEKER AENCP AENEX AEVXI AEYHU AFCTW AFKRA AFPKN AFRHN AFTJW AGABE AGHFR AGJUD AGUBO AGYEJ AHIPN AHRGI AITUG AJOXV AJPFC AJRQY AJUYK AKRWK ALIPV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AQJOH ASPBG AVWKF AZFZN AZQEC BENPR BLXMC BLZWO CCPQU CCQAD CCUQV CFBFF CGQII CITATION CJCSC CS3 CTKSN DOHLZ DU5 DWQXO EBS EGQIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYUFA G-Q GBLVA GNUQQ GROUPED_DOAJ HVGLF HZ~ IHE IKXGN IOO IPYYG J1W LN9 M2M M41 MO0 N9A NCXOZ NZEOI O-L O9- OAUVE OH0 OK1 OU- OZT P-8 P-9 P2P PC. PIMPY PSYQQ Q38 R2- RCA RIG ROL RPM RPZ SCC SDF SDG SDP SES SEW SSZ T5K UHS UKHRP UV1 WFFJZ Z5R ~G- 3V. 7XB 8FK COVID PQEST PQQKQ PQUKI PRINS Q9U 5PM |
ID | FETCH-LOGICAL-c2367-835946b8d45f3a7707bbc7007ff34dc5b74843fea801c335ec07736173fe9d933 |
IEDL.DBID | RPM |
ISSN | 0924-9338 |
IngestDate | Fri Oct 04 13:04:52 EDT 2024 Tue Sep 17 21:30:58 EDT 2024 Thu Oct 10 15:56:54 EDT 2024 Thu Sep 26 16:15:08 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | S1 |
Language | English |
License | This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2367-835946b8d45f3a7707bbc7007ff34dc5b74843fea801c335ec07736173fe9d933 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567183/ |
PQID | 2708717029 |
PQPubID | 4933639 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_e5ac1bdd75f5492a894046ceadf0b0a6 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9567183 proquest_journals_2708717029 crossref_primary_10_1192_j_eurpsy_2022_1037 |
PublicationCentury | 2000 |
PublicationDate | 20220601 |
PublicationDateYYYYMMDD | 2022-06-01 |
PublicationDate_xml | – month: 06 year: 2022 text: 20220601 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Paris |
PublicationPlace_xml | – name: Paris – name: Cambridge, UK |
PublicationTitle | European psychiatry |
PublicationYear | 2022 |
Publisher | Cambridge University Press |
Publisher_xml | – name: Cambridge University Press |
SSID | ssj0017006 |
Score | 2.3876553 |
Snippet | Introduction
Since the beginning of the pandemic, 4,745,519 cases, 396,878 hospitalizations and 82,884 deaths with COVID-19 have been reported in Spain. As of... IntroductionSince the beginning of the pandemic, 4,745,519 cases, 396,878 hospitalizations and 82,884 deaths with COVID-19 have been reported in Spain. As of... Introduction Since the beginning of the pandemic, 4,745,519 cases, 396,878 hospitalizations and 82,884 deaths with COVID-19 have been reported in Spain. As of... |
SourceID | doaj pubmedcentral proquest crossref |
SourceType | Open Website Open Access Repository Aggregation Database |
StartPage | S408 |
SubjectTerms | Abstract Bipolar disorder covid 19 COVID-19 vaccines dual disorder E-Poster Viewing Immunization Infections Pandemics Prevalence |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLojzEQlvNgRtETfxYr4_tlqogtVwo6i3yE5ZDNuq2lfhZ_YedsZNVw4UL1ziJHX8TzXzJzDeMfTAYA3ghbBWEQ4Ji7byyc7Rl7pJrrOTooql2-PxifnYpv16pq0etvignrMgDl407jMr6xoWgVSIxMbswEimdxw1ItattEdtu1Eimhv8Hus5dNWtkFxVS9sVYLmP44W9SVOw3f5Abcp5rzicuKSv3T8LNabLkI-9z-oI9H8JGOCrL3WVPYveSPT0ffoy_YvfLbT9BWCfor0nFm17aTzDWPkK8G8wMbBfgznq8NOMCJBcB9qddYawIy28_vpxAY2CFJ0K_bfCV71tUWDcQSoZeDEAfcuHkFu9_vOqJJ0MYBD3zNBfrrqJyL3B_jb5ml6efvy_PqqEbQ-VJ5a3CUM3IuVsEqZKwWtfaOY_7rFMSMnjlSJVUpGjR5yH6Kvpaa4EBEh4zAUF4w3a6dRffMvApGZk4xhY2Sme8iSK5KIxKUarQhBn7OALS9kV0o81kxXAkKwW-luBrCb4ZOybMtmeSYHY-gGbUDmbU_suMZmxvRLwd3uJNy3WNfFLX3MyYnljBZLLpSLf6lVW6kXii3xfv_sfq3rNn9LglRW2P7dxc38Z9DIZu3EG2-wfidA0- priority: 102 providerName: Directory of Open Access Journals – databaseName: Coronavirus Research Database dbid: COVID link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZgKyEu5S0WCpoDN0ibjZ14fUJ0S1WQWi4U9Rb5WRakbLqPSvCv-IfMOM5CeuDANQ_nMZ_tb-yZbxh7pZADWM515rhBB0XrKtMVYrkwwUy0KHCKptzh07Pq5Fx8vCgv0oLbKoVV9mNiHKjdwtIa-UEhc-T2Mi_U2_Yqo6pRtLuaSmjcZjt8ip7OiO3MPn35cLTdR5B5rK6Zo5eRoes-7dNmVHHwjZQV29UP9BGLIuaeD6amqOA_oJ3DoMm_ZqHje6zu378LPvm-v1mbffvzhrTj_3_gfbabCCq86xD1gN3yzUN25zRtwT9iv2bbyoWwCNAuSS-choc30GdZgr9OgAbdOLjWFm-NCAASpgB9qefISiH-RJgomOOF0G5LicV2O73XFbguFtA7oCVjONpg-4fzljxycEk6ND7mbNFklFgG5sbZx-z8-P3n2UmW6j5klvTkMiSFSlRm6kQZuJYyl8ZYtKQMgQtnS0P6pzx4jbMr4qz0NpeSIxXDY8qhmZ-wUbNo_FMGNgQlQoEsRnthlFWeB-O5KoMXpZu4MXvdm7xuO3mPOrpFqkC3qANITQCpCSBjdkio2F5J0tzxwGJ5WaeeXvtS24lxTpaB1O_0VIlcVBZ7bMhNrqsx2-vtX6fxYlX_Mf6YyQHOBg8bnmnmX6MeOLq4yDD4s383_JzdpQ_pwtz22Gi93PgXSKjW5mXqNb8Bdfon6g priority: 102 providerName: ProQuest |
Title | Comparison of prevalence, clinical evolution and vaccination rate against COVID 19 in a population of patients diagnosed with Dual Bipolar disorder and Non-dual bipolar disorder |
URI | https://www.proquest.com/docview/2708717029 https://pubmed.ncbi.nlm.nih.gov/PMC9567183 https://doaj.org/article/e5ac1bdd75f5492a894046ceadf0b0a6 |
Volume | 65 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLW2ISFeEJ-iMKr7wBtkdW0nrh9pt2kgtUyIob1F_tyCWBq12yR-Fv-QayepCI88Rcp3cq7jc5x7jwl5p5ADWM515rhBgaJ1kekCY5mZYKZaMOyiY-3wclWcXYjPl_nlHsn7WpiUtG9NdVT_vDmqq-uUW9nc2EmfJzY5Xy6Q0-MnlU_2yb7kvJfo3a8DSdOEmhSFRYZqfdZXyig2-RHNFJvtL5SFjKVy80FvlEz7B0xzmCf5V8dz-oQ87hgjfGzv7CnZ8_Uz8nDZ_RN_Tn4vdlMJwjpAs4kG3rG9foC-7BH8fRdhoGsH99rioQkSiE4RoK90hTQRFl--fzqGqYIKd4RmN7dXOm9rwLoF1ybneQdxDBeO7_D886qJEhlc5-WZLrNa11ms9ALzz9YX5OL05NviLOsmYshsNHjLkKUpUZiZE3ngWkoqjbH4nmUIXDibm2hIyoPX2N0h8Lm3VEqO3AjXKYcgvCQH9br2rwjYEJQIDGmF9sIoqzwPxnOVBy9yN3Uj8r4HpGxav40y6RTFUKe08JURvjLCNyLziNluz-iVnVasN1dlFzGlz7WdGudkHqIdnZ4pQUVhsQkFaqguRuSwR7zsGvC2ZJKilJSUqRGRgygYXGy4BeM1GXR38fn6v498Qx7FZ2xT0g7Jwe3mzr9F8nNrxuTB_GR1_hWXKSbGaRBhnJrAH5uDDw4 |
link.rule.ids | 230,315,733,786,790,870,891,2115,21416,27955,27956,33777,38549,43838,43928,53825,53827,74657,74767 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZgKwEX3hULBXzgBmmzthOvT4huqbbQXS4t6s3ysyxISdhHJfhX_EPGjrOQHjhwzcN5zGf7G3vmG4ReCeAAhlKVWarBQVGqzFQJWCba65FiBKbokDs8m5fTc_bhorhIC26rFFbZjYlxoLa1CWvkB4TnwO15TsTb5nsWqkaF3dVUQuMm2oGJlYwHaGfy6fPJ0XYfgeexumYOXkYGrvu4S5sR5OBrUFZsVj_ARyQk5p73pqao4N-jnf2gyb9moeN7SHbv3waffNvfrPW--XlN2vH_P_A-upsIKn7XIuoBuuGqh-jWLG3BP0K_JtvKhbj2uFkGvfAwPLzBXZYldlcJ0FhVFl8pA7dGBOAgTIHVpVoAK8XxJ-KRwAu4EDfbUmKx3VbvdYVtGwvoLA5LxvhoA-0fLprgkWObpEPjY-Z1lYXEMqyvnX2Mzo_fn02mWar7kJmgJ5cBKRSs1GPLCk8V5znX2oAlufeUWVPooH9KvVMwuwLOCmdyzilQMTgmLJh5Fw2qunJPEDbeC-YJsBjlmBZGOOq1o6LwjhV2ZIfodWdy2bTyHjK6RYKAW9QCRAaAyACQIToMqNheGaS544F6eSlTT5euUGakreWFD-p3aixYzkoDPdbnOlflEO119pdpvFjJP8YfIt7DWe9h_TPV4kvUAwcXFxgGffrvhl-i29Oz2ak8PZl_fIbuhI9qQ9720GC93LjnQK7W-kXqQb8BarAq0Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9NAEF1BK1VcEJ8iUGAO3MCK4931Zk-IJI1aoKFCFPVm7WcJB9skbSV-Fv-Q2fU6YA5cbWet-M163_POvCHklUQOYChVmaUaBYpSZaZKjOVCez1RrMAlOtQOn67K43P2_oJfpPynbUqr7N-J8UVtGxO-kY8LkSO3F3khxz6lRZwtlm_bH1noIBV2WlM7jdtkX7CSoxDbnx2tzj7v9hREHjtt5qg4MpTx076ERhbj78Flsd3-RL1YFLEOfbBMRTf_AQUdJlD-tSIt75G7iUrCuw77--SWqx-Qg9O0Wf6Q_JrvegxC46HdBGfvMJHfQF8PCe4mhR6o2sKNMvjTiBUECwlQl2qN_BHmn76eLGAiYY0XQrtr-hXH7ZxZt2C7rD1nIXzchcU1jj9bt0E7g00mn_E2q6bOQgkY6H_OPiLny6Mv8-MsdWjITHB-y5C-SVbqqWXcUyVELrQ2-JyF95RZw3VwKqXeKVwHMSK4M7kQFEkTHpMWQXhM9uqmdk8IGO8l8wXyDeWYlkY66rWjknvHuJ3YEXndA1K1nRFHFQWMLFDAdPBVAb4qwDcis4DZ7spgoh0PNJvLKs3JynFlJtpawX3wqVNTyXJWGpxbPte5KkfksEe8SjN7W_2JwxERgygY3Gx4pl5_i87dKEaRC9Cn_x_4JTnA0K4-nqw-PCN3wn_qctMOyd7V5to9RxZ0pV-k8P4NHHYMIg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+prevalence%2C+clinical+evolution+and+vaccination+rate+against+COVID+19+in+a+population+of+patients+diagnosed+with+Dual+Bipolar+disorder+and+Non-dual+bipolar+disorder&rft.jtitle=European+psychiatry&rft.au=B.+Losilla+Rodr%C3%ADguez&rft.au=F.+Palermo+Zeballos&rft.au=M.+Ortiz+Jim%C3%A9nez&rft.date=2022-06-01&rft.pub=Cambridge+University+Press&rft.issn=0924-9338&rft.eissn=1778-3585&rft.volume=65&rft.spage=S408&rft.epage=S409&rft_id=info:doi/10.1192%2Fj.eurpsy.2022.1037&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_e5ac1bdd75f5492a894046ceadf0b0a6 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0924-9338&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0924-9338&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0924-9338&client=summon |